{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:00:34Z","timestamp":1767211234945,"version":"3.37.3"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"5","funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2018CFB422"],"award-info":[{"award-number":["2018CFB422"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501253"],"award-info":[{"award-number":["81501253"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n<jats:title>Background and Objective:<\/jats:title>\n<jats:p>Although many trials have evaluated the use of dehydroepiandrosterone\nto improve outcomes in poor responders undergoing assisted reproductive technology\ntreatment, evidence supporting this approach is controversial. We aimed to conduct a systematic\nreview and meta-analysis of existing published data to further elucidate and supplement the use of\nDehydroepiandrosterone (DHEA) to improve the effectiveness of vitro fertilization in patients with\ndiminished ovarian reserve or adverse ovarian reactions.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>PubMed, Embase, Cochrane Library, and the Web of Science databases were searched\nthrough December 2020. Oocyte yield, metaphase II oocytes, fertilized oocytes, top-quality embryos,\nclinical pregnancy rate, ongoing pregnancy rate, and live birth rate were analyzed as relative outcomes.\nMeta-analysis was performed and fitted to both fixed-effects models and random-effects models.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Eight prospective randomized controlled studies, five prospective case-control studies, and\nthree retrospective cohort studies were conducted with a total of 1998 participants. Meta-analyses of\nthese studies showed a significantly higher number of oocytes retrieved (WMD 1.09, 95% CI 0.38\nto 1.80), metaphase II oocytes (WMD 0.78, 95% CI 0.16 to 1.40), fertilized oocytes (WMD 0.84,\n95% CI 0.42 to 1.26), top-quality embryos (WMD 0.60, 95% CI 0.34 to 0.86), clinical pregnancy\nrate (RR 1.35, 95% CI 1.13 to 1.61), and ongoing pregnancy rate (RR 1.82, 95% CI 1.34 to 2.46),\nalthough there was no difference in live birth rate (RR 1.35, 95% CI 0.94 to 1.94) in the DHEA supplementation\ngroups compared with that in the control groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Oral DHEA supplementation appears to improve some IVF outcomes. On the basis of\nthis limited evidence, we conclude that further studies are required to provide sufficient data.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207325666220820164357","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T04:38:00Z","timestamp":1661229480000},"page":"916-927","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Role of Dehydroepiandrosterone in Improving in vitro Fertilization\nOutcome in Patients with DOR\/POR: A Systematic Review and Meta-\nAnalysis"],"prefix":"10.2174","volume":"26","author":[{"given":"Bing","family":"Qu","sequence":"first","affiliation":[{"name":"Department of General Surgery, Renmin Hospital of\nWuhan University, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Reproductive Medical Center, Hubei Clinic Research Center for Assisted Reproductive Technology and Embryonic\nDevelopment, Renmin Hospital of Wuhan University, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Liu","sequence":"additional","affiliation":[{"name":"Reproductive Medical Center, Hubei Clinic Research Center for Assisted Reproductive Technology and Embryonic\nDevelopment, Renmin Hospital of Wuhan University, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wen","sequence":"additional","affiliation":[{"name":"School of Nursing, Tongji Medical College,\nHuazhong University of Science and Technology, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/01.AOG.0000264065.37661.a0","volume":"109","author":"Barad D.H.","year":"2007","unstructured":"Barad D.H.; Weghofer A.; Gleicher N.; Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 2007,109(6),1404-1410","journal-title":"Obstet Gynecol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1472-6483(10)60386-0","volume":"15","author":"Sunkara S.K.","year":"2007","unstructured":"Sunkara S.K.; Tuthill J.; Khairy M.; El-Toukhy T.; Coomarasamy A.; Khalaf Y.; Braude P.; Pituitary suppression regimens in poor responders undergoing IVF treatment: A systematic review and meta-analysis. Reprod Biomed Online 2007,15(5),539-546","journal-title":"Reprod Biomed Online"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrg3245","volume":"13","author":"Nagaoka S.I.","year":"2012","unstructured":"Nagaoka S.I.; Hassold T.J.; Hunt P.A.; Human aneuploidy: Mechanisms and new insights into an age-old problem. Nat Rev Genet 2012,13(7),493-504","journal-title":"Nat Rev Genet"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"Ferraretti A.P.","year":"2011","unstructured":"Ferraretti A.P.; La Marca A.; Fauser B.C.; Tarlatzis B.; Nargund G.; Gianaroli L.; ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: The Bologna criteria. Hum Reprod 2011,26(7),1616-1624","journal-title":"Hum Reprod"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"CD004379","DOI":"10.1002\/14651858.CD004379.pub3","author":"Pandian Z.","year":"2010","unstructured":"Pandian Z.; McTavish A.R.; Aucott L.; Hamilton M.P.; Bhattacharya S.; Interventions for \u2018poor responders\u2019 to controlled ovarian hyper stimulation (COH) in in vitro fertilisation (IVF). Cochrane Database Syst Rev 2010(1),CD004379","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0015-0282(02)02985-0","volume":"77","author":"Burger H.G.","year":"2002","unstructured":"Burger H.G.; Androgen production in women. Fertil Steril 2002,77(Suppl. 4),S3-S5","journal-title":"Fertil Steril"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.rbmo.2014.01.019","volume":"28","author":"Zangmo R.","year":"2014","unstructured":"Zangmo R.; Singh N.; Kumar S.; Vanamail P.; Tiwari A.; Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles. Reprod Biomed Online 2014,28(6),743-747","journal-title":"Reprod Biomed Online"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/humrep\/15.10.2129","volume":"15","author":"Casson P.R.","year":"2000","unstructured":"Casson P.R.; Lindsay M.S.; Pisarska M.D.; Carson S.A.; Buster J.E.; Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: A case series. Hum Reprod 2000,15(10),2129-2132","journal-title":"Hum Reprod"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1093\/humrep\/del254","volume":"21","author":"Barad D.","year":"2006","unstructured":"Barad D.; Gleicher N.; Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 2006,21(11),2845-2849","journal-title":"Hum Reprod"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10815-007-9178-x","volume":"24","author":"Barad D.","year":"2007","unstructured":"Barad D.; Brill H.; Gleicher N.; Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet 2007,24(12),629-634","journal-title":"J Assist Reprod Genet"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1093\/humrep\/deq220","volume":"25","author":"Wiser A.","year":"2010","unstructured":"Wiser A.; Gonen O.; Ghetler Y.; Shavit T.; Berkovitz A.; Shulman A.; Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: A randomized prospective study. Hum Reprod 2010,25(10),2496-2500","journal-title":"Hum Reprod"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3109\/09513590.2011.569611","volume":"27","author":"Weissman A.","year":"2011","unstructured":"Weissman A.; Horowitz E.; Ravhon A.; Golan A.; Levran D.; Dehydroepiandrosterone supplementation increases baseline follicular phase progesterone levels. Gynecol Endocrinol 2011,27(12),1014-1017","journal-title":"Gynecol Endocrinol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1111\/j.1743-6109.2011.02523.x","volume":"8","author":"Traish A.M.","year":"2011","unstructured":"Traish A.M.; Kang H.P.; Saad F.; Guay A.T.; Dehydroepiandrosterone (DHEA)-a precursor steroid or an active hormone in human physiology. J Sex Med 2011,8(11),2960-2982","journal-title":"J Sex Med"},{"key":"ref=14","first-page":"429","volume":"39","author":"Borman E.","year":"2012","unstructured":"Borman E.; Check J.H.; Mitchell-Williams J.; Cohen R.; No evidence to support the concept that low serum dehydroepiandrosterone (DHEA) sulfate (s) levels are associated with less oocyte production or lower pregnancy rates. Clin Exp Obstet Gynecol 2012,39(4),429-431","journal-title":"Clin Exp Obstet Gynecol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"139-145","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"DerSimonian R","year":"2015","unstructured":"DerSimonian R; Laird N;  Meta-analysis in clinical trials revisited Contemp Clin Trials 2015,45(Pt A),139-145","journal-title":"Meta-analysis in clinical trials revisited Contemp Clin Trials"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1136\/bmj.322.7300.1479","volume":"322","author":"Lewis S.","year":"2001","unstructured":"Lewis S.; Clarke M.; Forest plots: Trying to see the wood and the trees. BMJ 2001,322(7300),1479-1480","journal-title":"BMJ"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"Higgins J.P.","year":"2002","unstructured":"Higgins J.P.; Thompson S.G.; Quantifying heterogeneity in a meta-analysis. Stat Med 2002,21(11),1539-1558","journal-title":"Stat Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3109\/09513590.2012.705386","volume":"28","author":"Artini P.G.","year":"2012","unstructured":"Artini P.G.; Simi G.; Ruggiero M.; Pinelli S.; Di Berardino O.M.; Papini F.; Papini S.; Monteleone P.; Cela V.; DHEA supplementation improves follicular microenviroment in poor responder patients. Gynecol Endocrinol 2012,28(9),669-673","journal-title":"Gynecol Endocrinol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.mefs.2012.11.002","volume":"17","author":"Moawad A.","year":"2012","unstructured":"Moawad A.; Shaeer M.; Long-term androgen priming by use of dehydroepiandrosterone (DHEA) improves IVF outcome in poor-responder patients. A randomized controlled study. Middle East Fertil Soc J 2012,17(4),268-274","journal-title":"Middle East Fertil Soc J"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejogrb.2013.11.008","volume":"173","author":"Kara M.","year":"2014","unstructured":"Kara M.; Aydin T.; Aran T.; Turktekin N.; Ozdemir B.; Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve? Eur J Obstet Gynecol Reprod Biol 2014,173,63-65","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.fertnstert.2014.03.044","volume":"102","author":"Yeung T.W.","year":"2014","unstructured":"Yeung T.W.; Chai J.; Li R.H.; Lee V.C.; Ho P.C.; Ng E.H.; A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders. Fertil Steril 2014,102(1),108-115.e1","journal-title":"Fertil Steril"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejogrb.2016.02.009","volume":"200","author":"Kotb M.M.","year":"2016","unstructured":"Kotb M.M.; Hassan A.M.; AwadAllah, A.M. Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF\/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 2016,200,11-15","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref=23","first-page":"607","volume":"37","author":"Jing F.","year":"2017","unstructured":"Jing F.; Jiang H.; Lu L.; Xin A.; Sun Y.; Sun X.; Effect of dehydroepiandrosterone supplementation on the embryo quality and follicular fluid markers in patients with diminished ovarian reserve. Chinese Journal of Reproduction and Contraception 2017,37(8),607-613","journal-title":"Chinese Journal of Reproduction and Contraception"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejogrb.2017.09.006","volume":"218","author":"Narkwichean A.","year":"2017","unstructured":"Narkwichean A.; Maalouf W.; Baumgarten M.; Polanski L.; Raine-Fenning N.; Campbell B.; Jayaprakasan K.; Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial. Eur J Obstet Gynecol Reprod Biol 2017,218,39-48","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.rbmo.2014.10.005","volume":"30","author":"Vlahos N.","year":"2015","unstructured":"Vlahos N.; Papalouka M.; Triantafyllidou O.; Vlachos A.; Vakas P.; Grimbizis G.; Creatsas G.; Zikopoulos K.; Dehydroepiandrosterone administration before IVF in poor responders: A prospective cohort study. Reprod Biomed Online 2015,30(2),191-196","journal-title":"Reprod Biomed Online"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4103\/0974-1208.142477","volume":"7","author":"Jirge P.R.","year":"2014","unstructured":"Jirge P.R.; Chougule S.M.; Gavali V.G.; Bhomkar D.A.; Impact of dehydroepiandrosterone on clinical outcome in poor responders: A pilot study in women undergoing in vitro fertilization, using bologna criteria. J Hum Reprod Sci 2014,7(3),175-180","journal-title":"J Hum Reprod Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/jog.13456","volume":"43","author":"Lin L.T.","year":"2017","unstructured":"Lin L.T.; Cheng J.T.; Wang P.H.; Li C.J.; Tsui K.H.; Dehydroepiandrosterone as a potential agent to slow down ovarian aging. J Obstet Gynaecol Res 2017,43(12),1855-1862","journal-title":"J Obstet Gynaecol Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13048-017-0326-3","volume":"10","author":"Hu Q.","year":"2017","unstructured":"Hu Q.; Hong L.; Nie M.; Wang Q.; Fang Y.; Dai Y.; Zhai Y.; Wang S.; Yin C.; Yang X.; The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women. J Ovarian Res 2017,10(1),32","journal-title":"J Ovarian Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0300060517720005","volume":"46","author":"Al-Turki H.A.","year":"2018","unstructured":"Al-Turki H.A.; Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study. J Int Med Res 2018,46(1),143-149","journal-title":"J Int Med Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e99858","DOI":"10.1371\/journal.pone.0099858","volume":"9","author":"Xu B.","year":"2014","unstructured":"Xu B.; Li Z.; Yue J.; Jin L.; Li Y.; Ai J.; Zhang H.; Zhu G.; Effect of dehydroepiandrosterone administration in patients with poor ovarian response according to the Bologna criteria. PLoS One 2014,9(6),e99858","journal-title":"PLoS One"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12958-018-0409-z","volume":"16","author":"Chern C.U.","year":"2018","unstructured":"Chern C.U.; Tsui K.H.; Vitale S.G.; Chen S.N.; Wang P.H.; Cianci A.; Tsai H.W.; Wen Z.H.; Lin L.T.; Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: A retrospective cohort study. Reprod Biol Endocrinol 2018,16(1),90","journal-title":"Reprod Biol Endocrinol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3389\/fendo.2019.00800","volume":"10","author":"Chen S.N.","year":"2019","unstructured":"Chen S.N.; Tsui K.H.; Wang P.H.; Chern C.U.; Wen Z.H.; Lin L.T.; Dehydroepiandrosterone supplementation improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve. Front Endocrinol (Lausanne) 2019,10,800","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0015-0282(99)00630-5","volume":"73","author":"Surrey E.S.","year":"2000","unstructured":"Surrey E.S.; Schoolcraft W.B.; Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 2000,73(4),667-676","journal-title":"Fertil Steril"},{"key":"ref=34","author":"Fritz M.A.","year":"2011","unstructured":"Fritz M.A.; Speroff L.;  In: Clinical gynecologic endocrinology and infertility, 8th 2011","journal-title":"In: Clinical gynecologic endocrinology and infertility, 8th"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/humrep\/deh359","volume":"19","author":"Goswami S.K.","year":"2004","unstructured":"Goswami S.K.; Das T.; Chattopadhyay R.; Sawhney V.; Kumar J.; Chaudhury K.; Chakravarty B.N.; Kabir S.N.; A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: A preliminary report. Hum Reprod 2004,19(9),2031-2035","journal-title":"Hum Reprod"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.fertnstert.2007.11.055","volume":"91","author":"Mamas L.","year":"2009","unstructured":"Mamas L.; Mamas E.; Premature ovarian failure and dehydroepiandrosterone. Fertil Steril 2009,91(2),644-646","journal-title":"Fertil Steril"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1081\/DDC-100107328","volume":"27","author":"Minghetti P.","year":"2001","unstructured":"Minghetti P.; Cilurzo F.; Casiraghi A.; Montanari L.; Santoro A.; Development of patches for the controlled release of dehydroepiandrosterone. Drug Dev Ind Pharm 2001,27(7),711-717","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0531-5565(01)00232-7","volume":"37","author":"Ravaglia G.","year":"2002","unstructured":"Ravaglia G.; Forti P.; Maioli F.; Sacchetti L.; Nativio V.; Scali C.R.; Mariani E.; Zanardi V.; Stefanini A.; Macini P.L.; Dehydroepiandrosterone-sulfate serum levels and common age-related diseases: Results from a cross-sectional Italian study of a general elderly population. Exp Gerontol 2002,37(5),701-712","journal-title":"Exp Gerontol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/13697137.2011.571321","volume":"15","author":"Ethun K.F.","year":"2012","unstructured":"Ethun K.F.; Wood C.E.; Parker C.R.; Kaplan J.R.; Chen H.; Appt S.E.; Effect of ovarian aging on androgen biosynthesis in a cynomolgus macaque model. Climacteric 2012,15(1),82-92","journal-title":"Climacteric"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"653857","DOI":"10.3389\/fendo.2021.653857","volume":"12","author":"Neves A.R.","year":"2021","unstructured":"Neves A.R.; Montoya-Botero P.; Polyzos N.P.; The role of androgen supplementation in women with diminished ovarian reserve: Time to randomize, not meta-analyze. Front Endocrinol (Lausanne) 2021,12,653857","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207325666220820164357","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207818\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207325666220820164357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T11:26:52Z","timestamp":1682594812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207818\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207325666220820164357","relation":{},"ISSN":["1386-2073"],"issn-type":[{"type":"print","value":"1386-2073"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-02-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}